RK

Rakshith Katta Ramanjaneya

Active Director Additional Director DIN 10324486
DIN 10324486 First appointment Feb 2024 Primary industry Consumer Goods
Unlock full profile Investments · shareholding · contact details
Current companies 7 active board seats
Total affiliations 7 Since Feb 2024
Shareholding value •••• Premium profile

About Rakshith Katta Ramanjaneya

Data last updated:

Rakshith Katta Ramanjaneya is an Additional Director at Profit Shoe Company Private Limited (since 2025), Additional Director at Pelicon Homes Private Limited (since 2025) and Director at Smo Clinical Research (India) Private Limited (since 2024), and holds 4 more current directorships. The companies operate in Consumer Goods, Real Estate and Construction and Pharma. The 4 current companies with reported revenue have a combined latest revenue of ₹67.89 Cr; the largest is Profit Shoe Company Private Limited at ₹65.34 Cr (FY 2023).

DIN 10324486
Primary Designation Additional Director
Industry Consumer Goods
First Appointment 02 Feb 2024
Oldest Company Age 32 yrs
Largest company Profit Shoe Company Private Limited · ₹65.34 Cr (FY 2023)
Combined revenue ₹67.89 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Profit Shoe Company Private Limited U19201AP1995PTC019827
Additional Director10 Nov 20251995₹65.34 Cr (FY 2023)Active
Pelicon Homes Private Limited U45200AP1994PTC018395
Additional Director10 Nov 20251994₹1.98 Cr (FY 2023)Active
Director01 Mar 20242007₹30.4 Lakh (FY 2025)Active
Director01 Mar 20242007₹26.5 Lakh (FY 2025)Active
Designated Partner06 Jul 20262026Active
Additional Director10 Nov 20252008Active
Designated Partner02 Feb 20242024Active

Directorship timeline

Open interactive timeline →
Profit Shoe Company Private Limited
Pelicon Homes Private Limited
Profit Agro Farms India Private Limited
Smo Clinical Research (India) Private Limited
Premium access

Shareholding and investment profile for Rakshith Katta Ramanjaneya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rakshith Katta Ramanjaneya

Rakshith Katta Ramanjaneya currently holds 7 directorships: Profit Shoe Company Private Limited (Additional Director, since 10 Nov 2025, revenue ₹65.34 Cr (FY 2023)); Pelicon Homes Private Limited (Additional Director, since 10 Nov 2025, revenue ₹1.98 Cr (FY 2023)); Smo Clinical Research (India) Private Limited (Director, since 01 Mar 2024, revenue ₹30.4 Lakh (FY 2025)); Indya Clinical Research Private Limited (Director, since 01 Mar 2024, revenue ₹26.5 Lakh (FY 2025)); Regalis Consulting Llp (Designated Partner, since 06 Jul 2026); and 2 more.

Rakshith Katta Ramanjaneya was first appointed on 02 Feb 2024 as Designated Partner at Rkr Infratech Llp. The most recent appointment on record is 06 Jul 2026 at Regalis Consulting Llp.

The 4 current companies of Rakshith Katta Ramanjaneya that report revenue have a combined latest revenue of ₹67.89 Cr: Profit Shoe Company Private Limited ₹65.34 Cr (FY 2023); Pelicon Homes Private Limited ₹1.98 Cr (FY 2023); Smo Clinical Research (India) Private Limited ₹30.4 Lakh (FY 2025); Indya Clinical Research Private Limited ₹26.5 Lakh (FY 2025).

The current boards of Rakshith Katta Ramanjaneya's companies include Padma Latha Bodepudi (Profit Shoe Company Private Limited), Peraiah Battineni (Profit Shoe Company Private Limited), Siva Koteswara Rao Bodepudi (Profit Shoe Company Private Limited), Teja Bodepudi (Profit Shoe Company Private Limited), Jakkampudi Naga Sravani (Smo Clinical Research (India) Private Limited), Ramanjaneya Hanumanthappa Katta (Smo Clinical Research (India) Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available